CHSCM CHS Inc - Class B Reset Rate Cumulative Redeemable Preferred Stock, Series 3
CHSCM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
CHSCM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount |
|---|---|
| June 15, 2026 | $0.4220 |
| March 17, 2026 | $0.4220 |
| Dec. 16, 2025 | $0.4220 |
| Sept. 16, 2025 | $0.4220 |
| June 13, 2025 | $0.4220 |
| March 17, 2025 | $0.4220 |
| Dec. 17, 2024 | $0.4220 |
| Sept. 16, 2024 | $0.4220 |
| June 13, 2024 | $0.4220 |
| March 14, 2024 | $0.4220 |
| Dec. 13, 2023 | $0.4220 |
| Sept. 15, 2023 | $0.4220 |
| June 14, 2023 | $0.4220 |
| March 16, 2023 | $0.4220 |
| Dec. 15, 2022 | $0.4220 |
| Sept. 16, 2022 | $0.4220 |
| June 16, 2022 | $0.4220 |
| March 16, 2022 | $0.4220 |
| Dec. 16, 2021 | $0.4220 |
| Sept. 16, 2021 | $0.4220 |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CHSCM | — | — | — | — | — | — |
| BG | — | 29.7 | 32.4% | — | — | — |
| BG | — | 29.7 | 32.4% | — | — | — |
| DAR | $5.95B | 96.5 | 7.4% | 1.0% | 1.4% | 24.0% |
| INGR | $6.94B | 9.9 | -2.8% | 10.1% | 18.1% | 25.3% |
| CHSCP | — | — | — | — | — | — |
| ALCO | $265M | -1.8 | -5.5% | -334.4% | -83.2% | -436.2% |
| LMNR | $255M | -15.2 | -16.6% | -10.0% | -8.8% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 10
| Metric | Trend | Q2 2023 |
|---|---|---|
| Revenue | $11.31B | |
| Cost of Revenue | $10.92B | |
| Gross Profit | $384M | |
| SG&A Expense | $242M | |
| Operating Income | $142M | |
| Interest Expense | $36M | |
| Pretax Income | $313M | |
| Income Tax | $21M | |
| Net Income | $292M | |
| EBITDA | $142M |
Balance Sheet 17
| Metric | Trend | Q2 2023 |
|---|---|---|
| Cash & Equivalents | $462M | |
| Inventory | $4.86B | |
| Other Current Assets | $1.69B | |
| Current Assets | $10.62B | |
| PP&E (Net) | $4.74B | |
| Other Non-current Assets | $1.02B | |
| Total Assets | $20.17B | |
| Accounts Payable | $3.04B | |
| Accrued Liabilities | $665M | |
| Current Liabilities | $7.46B | |
| Other Non-current Liabilities | $1.06B | |
| Long-term Debt | $1.82B | |
| Total Debt | $1.95B | |
| Retained Earnings | $2.71B | |
| AOCI | $-257M | |
| Stockholders' Equity | $9.82B | |
| Liabilities + Equity | $20.17B |
Profitability 8
| Metric | Trend | Q2 2023 |
|---|---|---|
| Gross Margin | 3.4% | |
| Operating Margin | 1.3% | |
| Net Margin | 2.6% | |
| Pretax Margin | 2.8% | |
| EBITDA Margin | 1.3% | |
| ROA | 1.4% | |
| ROE | 3.0% | |
| ROIC | 1.1% |
Liquidity & Solvency 5
| Metric | Trend | Q2 2023 |
|---|---|---|
| Current Ratio | 1.4 | |
| Quick Ratio | 0.1 | |
| Debt / Equity | 0.2 | |
| LT Debt / Equity | 0.2 | |
| Interest Coverage | 4.0 |
Efficiency 2
| Metric | Trend | Q2 2023 |
|---|---|---|
| Asset Turnover | 0.6 | |
| Inventory Turnover | 2.1 |
Valuation (TTM) 2
| Metric | Trend | Q2 2023 |
|---|---|---|
| Revenue TTM | $47.54B | |
| Net Income TTM | $1.87B |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 2 filers · $747K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 0 (0 vs prior Q) | 1 (0 vs prior Q) | 0 (0 vs prior Q) | 0 (0 vs prior Q) | -800 |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| GRACE & WHITE INC /NY | $584,888 | 24,229 | 78.26% | Shares |
| IMA Advisory Services, Inc. | $162,438 | 6,729 | 21.74% | Shares |
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.